Foreword xv Acknowledgment xvii 1 Empowering Marginalized Communities: Legal and Policy Levers for Health Equity 1 1.1 Navigating Law, Policy, and Health Inequities 1 1.2 The Purpose and Importance of Examining Health Equity Through Law and Policy 2 1.3 Key Concepts and Definitions 3 1.4 An Ecosystem Approach to Health Equity Law and Policy 4 1.5 An Urgent Imperative 5 1.6 Conclusion: A Roadmap for Equitable Policy Change 5 References 6 Part I Health Care: Examining Access and Quality 9 2 Narrowing Health Access Disparities: The Affordable Care Act and Medicaid Expansion 11 2.1 Health Disparities and Insurance Coverage in America: A Century of Change 12 2.

2 The ACA''s Mechanics and Effectiveness 13 2.2.1 How Did the ACA Increase Health Insurance Coverage? 13 2.2.2 The ACA''s Effectiveness 14 2.3 Ramifications of an ACA Repeal 14 2.4 Conclusion: The ACA''s Impact on Health Equity Amid Ongoing Challenges 15 References 17 3 Tackling Insulin Affordability: Addressing Systemic Failures and Policy Solutions 19 3.1 Insulin Affordability: Progress, Disparities, and the Need for Systemic Change 20 3.

2 State Initiatives on Insulin Affordability: An Overview 21 3.2.1 State-Mandated Diabetes Coverage: Benefits and Limitations 22 3.2.2 State Copay Caps: Limited Impact and Scope 22 3.2.3 State Insulin Safety Net Program: A Limited Solution 22 3.2.

4 Biosimilar Insulin: Interchangeability, State Initiatives, and Challenges 23 3.3 Federal Efforts and the Inflation Reduction Act for Insulin Affordability 23 3.4 Policy Recommendations 24 3.5 Conclusion: Addressing Systematic Failures for Equitable Insulin Access 26 References 26 4 Ensuring Equitable Healthcare: Overcoming Language Barriers Through Policies 29 4.1 Challenges and Implications of Language Barriers in Healthcare 30 4.2 Federal Laws Addressing Language Needs in Healthcare 31 4.2.1 Federal Authority and Related Standards and Guidance 31 4.

2.2 The Affordable Care Act 32 4.2.3 Additional Federal Laws and Funding 33 4.3 State Initiatives 33 4.4 Recent Developments and Practical Challenges 34 4.5 Conclusion: Charting a Path to Linguistically Inclusive Healthcare 35 References 36 5 Confronting the US Maternal Mortality Crisis: Addressing Racial Disparities 39 5.1 Racial Disparities Fuel US Maternal Mortality Crisis 40 5.

2 Preventable Deaths: Addressing Systemic Barriers via Policy 41 5.2.1 Federal Initiatives: Driving Change in Maternal Health 41 5.2.2 State-Level Initiatives: Medicaid Expansion and Targeted Interventions 42 5.3 Overcoming Fragmentation: Collaboration and Bias Training 44 5.4 Conclusion: Strengthening Legislation: Equity-Focused Interventions 45 References 45 6 Mitigating Algorithmic Bias in Healthcare AI for Equitable Care 47 6.1 Addressing Algorithmic Bias in AI to Ensure Fair Healthcare 48 6.

2 Legal Landscape and Challenges in Regulating Algorithmic Bias in Healthcare AI 48 6.3 Collaborative Efforts to Address Algorithmic Bias in Healthcare AI 49 6.3.1 Enhancing Data Quality and Diversity to Address Algorithmic Bias 50 6.3.2 Regulatory Oversight and Transparency in Medical AI Development and Implementation 50 6.3.3 Diverse Teams and Inclusive Datasets: Strategies for Mitigating Algorithmic Bias 51 6.

4 Conclusion: Overcoming Challenges in Addressing Racial Bias in Medical AI 52 References 53 7 Confronting Inequities in the US Organ Transplant System 55 7.1 Inequities in Organ Transplantation Disproportionately Affect Communities of Color 56 7.2 Barriers to Specialist Referrals and Data Gaps Perpetuate Inequities 57 7.3 Race-Based Clinical Policies Hinder Equitable Waitlist Placement 57 7.4 Waitlist Policies Favor Socioeconomically Advantaged Patients 57 7.5 Communication Barriers and Resource Limitations Hinder Diverse Organ Donation 58 7.6 Provider Bias and Insurance Disparities Impede Black Patients'' Transplant Access 58 7.7 OPTN Mandates Race-Neutral Transplant Eligibility Calculations 58 7.

8 Recommendations for Improving Equity at Each Stage of the Transplant Process 59 7.9 Discrimination Based on Disability in Organ Transplantation Persists 60 7.10 A Comprehensive, Multistage Approach for Equitable Organ Allocation 60 References 61 8 Transforming Blood Donation: Path to Inclusivity and Science-Based Guidelines 65 8.1 Updated FDA Blood Donation Guidelines Promote Inclusivity and Safety 66 8.2 The Evolution of FDA Blood Donation Policies for Men Who Have Sex with Men 67 8.3 Challenging the Constitutionality of FDA''s MSM Blood Donation Policies 68 8.4 FDA''s New Guidelines Combat Stigma and Promote Inclusivity 70 8.5 Conclusion: Rebuilding Trust and Encouraging Inclusive Blood Donation 70 References 71 9 Addressing Barriers and Disparities in Clinical Trials: FDA''s Diversity Plan 73 9.

1 Enhancing Diversity in Clinical Trials: Addressing Barriers and Disparities 74 9.2 Legislative and Regulatory Efforts to Enhance Clinical Trial Diversity 75 9.3 Potential Impact of Diversity in Clinical Trials on Medical Outcomes 76 9.4 Limitations and Challenges in Enforcing Diversity Requirements 77 9.5 Strategies to Increase Access and Participation in Clinical Trials 77 9.6 Incentives and Post-Approval Requirements to Promote Diversity 78 9.7 Conclusion: Future Steps and Expanding Diversity Efforts 78 References 79 10 Strengthening the Safety Net to Mitigate Reproductive Health Inequity After Dobbs 83 10.1 Reproductive Health Inequities Post-Dobbs 84 10.

2 Maternal Health Inequities Deepen Post-Dobbs 85 10.3 The Critical Role of Safety-Net Providers 86 10.4 Advancing Equity Through Research 88 10.5 Conclusion: Advancing Equity Amid Reproductive Crisis 89 References 89 11 Advancing Mental Health Equity Through Policies 93 11.1 Disparities in Mental Health Care 94 11.2 Major Shifts Needed 95 11.3 Addressing Root Causes 96 11.4 States as Laboratories for Innovation 97 11.

5 Conclusion: Urgency for Mental Health Reform 98 References 99 Part II Health Behaviors: Exploring the Influences of Exercise, Diet, and Drug Use 103 12 Promoting Physical Activity: Policy Strategies for Equity and Engagement 105 12.1 Tackling the Global Inactivity Crisis: WHO''s Action Plan for a Healthier World 106 12.2 Addressing Inequities in Physical Activity: Inclusive Strategies and Community Engagement 106 12.3 Implementing Inclusive Health Equity Strategies: CDC Guidelines and Community Examples 107 12.4 Leveraging Legal Strategies and Policy Domains to Promote Physical Activity and Address Inequities 108 12.5 Conclusion: Overcoming Challenges in Promoting Physical Activity for Youth of Color 110 References 110 13 Reducing Sugary Beverage Consumption: Regulatory Measures 113 13.1 Consequences of Sugary Drink Consumption 114 13.2 Factors Driving Sugary Drink Consumption Disparities in Communities of Color 114 13.

2.1 Sugary Drink Consumption Disparities Among Racial and Ethnic Groups 114 13.2.2 Targeted Marketing of Sugary Drinks to Minority Youth 115 13.2.3 Limited Access to Healthy Options in Minority Neighborhoods 115 13.3 Limitations of Current Policies Addressing Sugary Drink Consumption 116 13.4 Policy Strategies for Reducing Sugary Drink Consumption 117 13.

4.1 A National Sugary Drink Tax: Recommendations and Considerations 117 13.4.2 Promoting Healthier School Meals and Reallocating Agricultural Subsidies 118 13.5 Conclusion: A Comprehensive Approach to Reducing Sugary Drink Consumption 118 References 119 14 Promoting Health Equity via Tobacco Control 123 14.1 Tobacco-Related Disparities 124 14.2 Strategies for Policy Interventions to Foster Health Equity 125 14.2.

1 Implementation of Smoke-Free Laws 126 14.2.2 Investment in Anti-tobacco Education and Ad Campaigns 126 14.2.3 Investment in Tobacco Cessation Programs 126 14.2.4 Increase in the Cost of Tobacco Products 127 14.2.

5 Regulation of Tobacco Product Sales 127 14.2.6 Raising the Minimum Age for Tobacco Purchases 127 14.2.7 Strengthening Enforcement 127 14.3 Strategizing Policy Implementation to Enhance Health Equity 127 14.3.1 The Comprehensive Approach 128 14.

3.2 Minimizing Unintended Consequences 128 14.3.3 Promoting Investment in Tobacco Control 128 14.4 Conclusion: Achieving Equity in Tobacco Control 129 References 130 15 Tackling the Overdose Crisis Through Equitable Harm Reduction Policies 133 15.1 The Need for an Equity-Centered, Harm Reduction Approach 134 15.2 Expanding Access to Naloxone 135 15.3 Providing Safer Use Supplies and Services 135 15.

4 Expanding Access to Evidence-Based Treatment 136 15.5 Addressing Structural Determinants and Promoting Health Equity 136 15.6 Investing in Community Development 137 15.7 Reforming the Criminal Justice System 137 15.8 Addressing Stigma and Misconceptions 137 15.9 Enhancing Data Collection and Oversight 138 15.10 Conclusion: Leveraging Resources and Centering Equity in the Fight Against the Opioid Crisis 138 References 140 16 Confronting the HIV/A.